Akorn Seeks OK On $30M Deal Over Failed Merger
Pharmaceutical manufacturer Akorn Inc. and its investors settled a suit that would provide $30 million in cash and distribute more than 8 million shares of Akorn stock to class members, according to a...To view the full article, register now.
Already a subscriber? Click here to view full article